Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

$100m-$499m

CureFit starts training for $100m round
Temasek could reportedly invest in CureFit at a valuation of $800m, three years after UC-RNT Fund supplied $25m to the wellness services provider.
Psiquantum swings $230m
University of Bristol-founded Psiquantum has reportedly scooped funding from backers including an Andy Rubin fund as it looks to develop silicon-powered quantum computers.
eGenesis brings about $100m series B
Harvard's xenotransplantation technology developer eGenesis has raised a $100m in its series B round.
Databricks builds $400m series F
Andreessen Horowitz has led a $400m round for the data preparation software provider based on UC Berkeley research, more than doubling its valuation to $6.2bn in eight months.
CMR Surgical completes $240m series C operation
Cambridge Innovation Capital has returned a second time to back a $240m series C for CMR Surgical, helping bring the surgical robotics company's total funding to $386m.
Trifacta wrangles $100m
Trifacta, co-founded by Stanford and UC Berkeley researchers, has attracted nearly a dozen investors for a round that brought its total funding to $224m.
CAS helps GKHT source $154m
Cash Capital has contributed to a a series C round for medical supplies provider GKHT, established as an affiliate of the Chinese Academy of Sciences-owned Osic Holding Group.
Passage Bio packs in another $110m
University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.

Other News

Achilles Therapeutics accesses $120m
UCL and Francis Crick-founded Achilles has raised series B funding at a reported $228m valuation and will now look to advance lung cancer and melanoma treatments.
Kronos cracks $105m series A
GV contributed to a round for MIT-founded small molecule cancer drug spinout Kronos Bio, adding to $18m raised by the latter 14 months ago.
Recursion reconciles $121m
The series C for Utah-founded drug discovery platform creator Recursion included capital from University of Minnesota and Texas Tech University System.
Biontech completes $325m series B
Fidelity Management & Research has led a $325m series B round for Biontech, a spinout of Johannes Gutenberg University Mainz whose backers also include Sanofi and Pfizer.
Revolution celebrates $100m
Third Rock contributed to a $100m series C round for UIC's cancer drug developer Revolution that brought its total to $226m.
Tier IV tears it up to raise $105m
Sompo Japan Nipponkoa led the Utec-backed autonomous vehicle software developer's series A round, which included Yamaha Motor, Aisan Technology and existing investor KDDI.

Editor's Picks

Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Immunocore smashes European biotech records
Immunotherapy firm Immunocore, which started life at Oxford University, raises the largest biotech round in European history.
test reg

Login